Mastek UK arm to drive NHS digital transformation, named supplier on DTCS framework

The four-year framework replaces the former Clinical Digital Professional Services (CDPS) agreement and is intended to accelerate the procurement of high-quality clinical digital solutions and infrastructure in UK’s healthcare sector. Shares of Mastek Ltd ended at ₹2,448.50, down by ₹41 or 1.65%, on the BSE today (Sept 5).

Leave a Reply

Your email address will not be published. Required fields are marked *